Beth Faiman
@bethfaiman.bsky.social
Fortunate to speak to colleagues in Brasil / Portuguese about #MM and #CART, #bispecifics. What a unique honor @mmkingt.bsky.social
September 24, 2024 at 11:19 AM
Fortunate to speak to colleagues in Brasil / Portuguese about #MM and #CART, #bispecifics. What a unique honor @mmkingt.bsky.social
Reposted by Beth Faiman
There's very little published on #rehabilitation in #CAR-T.
A short report sharing insights from our service pilot of #physiotherapy input before and after CAR-T @UCLH has been published in eJHaem
onlinelibrary.wiley.com/doi/10.1002/...
A short report sharing insights from our service pilot of #physiotherapy input before and after CAR-T @UCLH has been published in eJHaem
onlinelibrary.wiley.com/doi/10.1002/...
Single‐centre experience of implementing physiotherapist‐led prehabilitation for chimeric antigen receptor T cell therapy
Introduction This report outlines the evaluation of physiotherapist-led prehabilitation/rehabilitation for recipients of chimeric antigen receptor T (CAR-T) cell therapy. Methods A hybrid approach...
onlinelibrary.wiley.com
September 24, 2024 at 11:06 AM
There's very little published on #rehabilitation in #CAR-T.
A short report sharing insights from our service pilot of #physiotherapy input before and after CAR-T @UCLH has been published in eJHaem
onlinelibrary.wiley.com/doi/10.1002/...
A short report sharing insights from our service pilot of #physiotherapy input before and after CAR-T @UCLH has been published in eJHaem
onlinelibrary.wiley.com/doi/10.1002/...
On our way
September 20, 2024 at 1:47 AM
Reposted by Beth Faiman
Nurse/AH welcome all to join us @myeloma-society.bsky.social travel safe - c u in Rio!
events.jspargo.com/ims24/CUSTOM...
events.jspargo.com/ims24/CUSTOM...
September 15, 2024 at 12:37 AM
Nurse/AH welcome all to join us @myeloma-society.bsky.social travel safe - c u in Rio!
events.jspargo.com/ims24/CUSTOM...
events.jspargo.com/ims24/CUSTOM...
Reposted by Beth Faiman
Don't miss this Meet the Expert session on Saturday, September 28 at #IMS24. Register now!➡️ rb.gy/1h136x
September 16, 2024 at 4:04 PM
Don't miss this Meet the Expert session on Saturday, September 28 at #IMS24. Register now!➡️ rb.gy/1h136x
T-14 days until #IMS24! @rahulbanerjeemd.bsky.social
Are you ready for #IMS24?🤩 In just a few weeks, professionals from around the globe will gather to explore the latest in #myeloma research. Don’t be left behind! Whether in Rio de Janeiro or virtually, be part of the experience. Register today! ➡️ rb.gy/1h136x
September 10, 2024 at 11:00 PM
T-14 days until #IMS24! @rahulbanerjeemd.bsky.social
Reposted by Beth Faiman
1/ And since we can’t tweet during #IMS24, also worth highlighting CEPHEUS as another LBA!
D-VRd vs VRd in ASCT-ineligible #MMsm - large PFS benefit with CD38 addition even if no ASCT. Love simplicity of the last line: ASCT decision-making should not dictate induction choice!
D-VRd vs VRd in ASCT-ineligible #MMsm - large PFS benefit with CD38 addition even if no ASCT. Love simplicity of the last line: ASCT decision-making should not dictate induction choice!
September 8, 2024 at 1:30 PM